We read with interest the study by HWANG et al., which continues the discussion on factors associated with poor outcomes in the treatment ofmultidrug-resistant tuberculosis (MDRTB) and extensively drug-resistant tuberculosis (XDR-TB)
Introduction The crucial therapeutic issue in MDR and XDR-TB is the difficulty of identifying at lea...
Information on treatment outcomes among hospitalized patients with multidrug-resistant tuberculosis ...
A pilot programme to treat multidrug-resistant TB (MDR-TB) was implemented in Karakalpakstan, Uzbeki...
We read with interest the study by HWANG et al., which continues the discussion on factors associat...
The article by Kim et al. about the impact of extensively drug-resistant (XDR) tuberculosis (TB) on...
RATIONALE: Few large-scale studies have investigated multidrug-resistant tuberculosis (MDR-TB) treat...
Recently, resistance to additional first-line and injectable drugs was reported to be an independent...
<p>MDR = resistance to at least isoniazid and rifampin.</p><p>Simple MDR = resistance to only isonia...
Rationale: Few large-scale studies have investigated multidrug-resistant tuberculosis (MDR-TB) treat...
ABSTRACT: Recently, resistance to additional first-line and injectable drugs was reported to be an i...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB) are increasing ...
<p>OR = odds ratio.</p><p>CI = confidence interval.</p><p>MDR = resistance to at least isoniazid and...
Drug resistance is a major hurdle in the global battle against tuberculosis (TB). In tackling this p...
Multidrug-resistant tuberculosis (MDR-TB) is the biggest health concerns in the world today, due to ...
RATIONALE: The increasing worldwide incidence of extensively drug-resistant tuberculosis (XDR-TB) ha...
Introduction The crucial therapeutic issue in MDR and XDR-TB is the difficulty of identifying at lea...
Information on treatment outcomes among hospitalized patients with multidrug-resistant tuberculosis ...
A pilot programme to treat multidrug-resistant TB (MDR-TB) was implemented in Karakalpakstan, Uzbeki...
We read with interest the study by HWANG et al., which continues the discussion on factors associat...
The article by Kim et al. about the impact of extensively drug-resistant (XDR) tuberculosis (TB) on...
RATIONALE: Few large-scale studies have investigated multidrug-resistant tuberculosis (MDR-TB) treat...
Recently, resistance to additional first-line and injectable drugs was reported to be an independent...
<p>MDR = resistance to at least isoniazid and rifampin.</p><p>Simple MDR = resistance to only isonia...
Rationale: Few large-scale studies have investigated multidrug-resistant tuberculosis (MDR-TB) treat...
ABSTRACT: Recently, resistance to additional first-line and injectable drugs was reported to be an i...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB) are increasing ...
<p>OR = odds ratio.</p><p>CI = confidence interval.</p><p>MDR = resistance to at least isoniazid and...
Drug resistance is a major hurdle in the global battle against tuberculosis (TB). In tackling this p...
Multidrug-resistant tuberculosis (MDR-TB) is the biggest health concerns in the world today, due to ...
RATIONALE: The increasing worldwide incidence of extensively drug-resistant tuberculosis (XDR-TB) ha...
Introduction The crucial therapeutic issue in MDR and XDR-TB is the difficulty of identifying at lea...
Information on treatment outcomes among hospitalized patients with multidrug-resistant tuberculosis ...
A pilot programme to treat multidrug-resistant TB (MDR-TB) was implemented in Karakalpakstan, Uzbeki...
DOI
Add to ORKG